NCT06831045

Brief Summary

The study team is conducting this study to see if there is a difference between the wound healing and participant satisfaction rates between two incision types used during a THA done via the DAA technique.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
110

participants targeted

Target at P50-P75 for not_applicable

Timeline
24mo left

Started Mar 2025

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress38%
Mar 2025Apr 2028

First Submitted

Initial submission to the registry

February 13, 2025

Completed
4 days until next milestone

First Posted

Study publicly available on registry

February 17, 2025

Completed
12 days until next milestone

Study Start

First participant enrolled

March 1, 2025

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2028

Last Updated

March 18, 2026

Status Verified

March 1, 2026

Enrollment Period

3.1 years

First QC Date

February 13, 2025

Last Update Submit

March 17, 2026

Conditions

Outcome Measures

Primary Outcomes (3)

  • Wound Healing measured in number of days

    Will be measured in number of days the incision will take to heal.

    Up to 14 days

  • Patient satisfaction with scaring as measured by Patient Scar Assessment Scale

    Score ranges from 0 to 10. Higher scores indicate less satisfaction

    Up to to 6 months

  • Scar cosmesis as measured by Observer Scar Assessment Scale

    Score ranges from 0 to 10. Higher scores indicate worse scar cosmesis

    Up to 6 months

Secondary Outcomes (5)

  • Number of participants who report lateral femoral cutaneous nerve-related symptoms

    Up to 6 months

  • Patient reported outcomes as measured by Hip Disability and Osteoarthritis Outcomes

    Up to 6 months

  • Number of intraoperative fractures

    Up to 3 hours

  • Length of surgery measured in minutes

    Up to 3 hours

  • Number of postoperative complications

    Up to 90 days

Study Arms (2)

Bikini Incision Group

EXPERIMENTAL

Participants in this group will receive the bikini incision during THA. Total participation is up to 90 days.

Procedure: Bikini Incision

Longitudinal Incision Group

EXPERIMENTAL

Participants in this group will receive the longitudinal incision during THA. Total participation is up to 90 days.

Procedure: Longitudinal Incision

Interventions

Participants will receive the bikini incision in person during THA. A one-time incision will be made along the groin line before standard of care THA surgery. The surgery takes approximately two hours.

Bikini Incision Group

Participants will receive the longitudinal incision in person during THA. A one-time linear incision will be made along the thigh before standard-of-care THA surgery. The surgery takes approximately two hours.

Longitudinal Incision Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with body mass index greater than or equal to 30
  • Patients undergoing primary unilateral DAA THA
  • Patients undergoing primary THA

You may not qualify if:

  • Patients with body mass index less than 30
  • Patients with a history of prior open surgery on the affected hip
  • Patients unable/unwilling to undergo spinal anesthesia under monitored anesthesia care (MAC)
  • Patients with allergies or absolute contraindication to standardized drugs administered within the University of Miami protocol for total hip replacement
  • The following groups will not be included: adults unable to consent, individuals who are not yet adults, pregnant women, prisoners.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Miami

Miami, Florida, 33136, United States

RECRUITING

Study Officials

  • Victor H Hernandez, MD

    University of Miami

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Victor H Hernandez, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Clinical Orthopedics

Study Record Dates

First Submitted

February 13, 2025

First Posted

February 17, 2025

Study Start

March 1, 2025

Primary Completion (Estimated)

April 1, 2028

Study Completion (Estimated)

April 1, 2028

Last Updated

March 18, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations